The Physical Compatibility of Clinically Used Concentrations of Diltiazem Hydrochloride With Heparin Sodium

Sydney R Dobson1, Vincent F Mauro1, Sai H S Boddu2

  • 1University of Toledo, Toledo, OH, USA.

Insights

Higher concentration diltiazem (5 mg/mL) is incompatible with heparin infusions. Lower concentration diltiazem (1 mg/mL) with heparin is physically compatible, but chemical stability requires further study.

Area of Science:

  • Critical care medicine
  • Cardiology
  • Pharmacology

Background:

  • Acute treatment of atrial fibrillation often necessitates concurrent intravenous infusions of unfractionated heparin and diltiazem.
  • Co-infusion via a single IV line minimizes venipuncture sites.
  • Previous compatibility studies had limitations in drug concentrations and dwell times.

Purpose of the Study:

  • To assess the physical compatibility of diltiazem hydrochloride at 5 mg/mL and 1 mg/mL with heparin sodium at 100 units/mL.
  • To determine compatibility through visual inspection, spectrophotometry, and pH monitoring.

Main Methods:

  • Heparin sodium (100 units/mL) was mixed with equal volumes of diltiazem hydrochloride (5 mg/mL or 1 mg/mL) in PVC bags.
  • Admixtures were analyzed in triplicate for visual precipitation, turbidity, absorbance, and pH at specified time points up to 24 hours.
  • Physical incompatibility criteria included visual changes, increased absorbance, and significant pH shifts.

Main Results:

  • Diltiazem 5 mg/mL admixtures showed haze and increased absorbance, indicating turbidity.
  • No significant pH changes were observed with the 5 mg/mL diltiazem admixture.
  • Diltiazem 1 mg/mL admixtures exhibited no visual precipitation or turbidity, with only one minor pH fluctuation.

Conclusions:

  • Co-infusion of diltiazem hydrochloride 5 mg/mL with heparin sodium 100 units/mL is not recommended due to physical incompatibility.
  • Diltiazem hydrochloride 1 mg/mL appears physically compatible with heparin sodium 100 units/mL, although chemical stability was not evaluated.

Related Concept Videos

Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers01:20

Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers

Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
1.1K
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.0K
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.4K
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations01:15

Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations

Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
16
Drug Dissolution: Requirements and Profile Comparison01:14

Drug Dissolution: Requirements and Profile Comparison

The acceptance criteria for dissolution profile data are anchored in Q values, representing the percentage of drug dissolved within a specified period. This assessment unfolds in three stages:First Stage: The test passes if all six drug dosage units are equal to or greater than Q plus 5%; otherwise, the sample proceeds to the second stage.Second Stage: The average of twelve units must be equal to or greater than Q, with no unit falling below Q - 15% to pass; if not, it progresses to the final...
35
Time Course of Drug Effect01:14

Time Course of Drug Effect

The progression of a drug's impact can be analyzed by examining both the concentration-time course and the effect-time course. The concentration-time course is determined by the drug's half-life and is influenced by factors such as its pharmacokinetics, including absorption, distribution, metabolism, and elimination. The effect of the drug is often related to its concentration in the plasma and is calculated using the maximum drug effect and the plasma concentration that generates 50...
2.3K